Research & Projects

The Yale Glaucoma Research Group is dedicated to advancing the understanding and treatment for glaucoma. Our mission is to actively advance the field through innovative and clinically important research. Ultimately, we hope to advance the field of glaucoma to the point of preventing blindness and optimizing patient outcomes.

To optimally treat glaucoma, we strive to maximize our understanding of glaucoma as well as maximize community awareness and detection of the disease. The glaucoma team at Yale has been working on optimizing treatment options for patients by analyzing the effects and outcomes for various procedures including micro invasive procedures such as Trabectome, Dual Blade Goniotomy, Micropulse Cyclophotocoagulation, and iStent, laser procedures such as trabeculoplasty, iridoplasty, and iridotomy and traditional glaucoma surgeries.

Additionally, the Group has investigated the role of alternative medications as treatment options for glaucoma as well as the role of new imaging instrumentation such as OCT angiography. Other areas of interest include optimizing resident education and training, improving patient education and access to care, utilizing artificial intelligence and machine learning to optimize patient care, and increasing diversity and inclusivity in ophthalmology.